403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Erzurum: Most patients in severe care not immunized against coronavirus in Turkey’s
(MENAFN) A health official said the occupancy volume at severe care units in Turkey’s eastern Erzurum province stood at 90 percent in the epidemic.
Ibrahim Hakki Tor, a faculty member at Erzurum City Hospital informed Anadolu Agency that almost 95 percent of patients in severe care did not receive the inoculation.
Tor continued “I believe that as the vaccination rate increases, there will be no closure and restrictions in the city and the burden on the health community will decrease accordingly.”
He also marked that in the first levels of the pandemic, the volume of the old inhabitants was soaring in severe care units.
Moreover, he underlined “As time progressed, we carried out a serious vaccination campaign for our elderly population across the country, and accordingly, we observed a significant decrease in the elderly population hospitalized in the intensive care units.”
Ibrahim Hakki Tor, a faculty member at Erzurum City Hospital informed Anadolu Agency that almost 95 percent of patients in severe care did not receive the inoculation.
Tor continued “I believe that as the vaccination rate increases, there will be no closure and restrictions in the city and the burden on the health community will decrease accordingly.”
He also marked that in the first levels of the pandemic, the volume of the old inhabitants was soaring in severe care units.
Moreover, he underlined “As time progressed, we carried out a serious vaccination campaign for our elderly population across the country, and accordingly, we observed a significant decrease in the elderly population hospitalized in the intensive care units.”
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment